CSM Corbion NV

Corbion signs a new debt issuance for USD 100 million in the US Private Placement market

Corbion signs a new debt issuance for USD 100 million in the US Private Placement market

Corbion announces the signing of a Note Purchase Agreement for a total debt issuance of USD 100 million in the US Private Placement (USPP) market, with a fixed interest rate of 5.11% and a maturity of 7 years.

The final closing, issuance of notes, and funding are scheduled for December 18, 2025; subject to standard closing conditions. The proceeds from this USPP will be used to repay maturing debt due in December 2025. This program will further align the well-spread maturity profile of Corbion’s outstanding debt.



Disclaimer

Corbion offered the notes to certain institutional investors in an exempt private placement made pursuant to an exemption from the registration requirements under the U.S. Securities Act of 1933, as amended (the “Act”). The notes have not been and will not be registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Act.

This announcement does not constitute an offer to sell or the solicitation of an offer to buy any security, in the United States or elsewhere, and in any event shall not constitute an offer, solicitation, or sale of any securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful.

Attachment



EN
07/11/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Corbion NV

 PRESS RELEASE

Corbion published agenda for AGM

Corbion published agenda for AGM Corbion has published its agenda for the upcoming Annual General Meeting of Shareholders (AGM) to be held on 13 May 2026. The full AGM agenda together with explanatory notes is available on Corbion's under Investor relations --> Shareholder information --> Shareholder meetings. Attachment

Reg Watson ... (+2)
  • Reg Watson
  • CFA

Corbion/Goldilocks scenario extends/HOLD

Since our 12-month target price upgrade to €18.60 and change in recommendation from Sell to HOLD on 17 November 2025, Corbion has delivered its Capital Markets Day and full year results. Corbion confirmed at its 2025 results that the company had taken advantage of the low sugar price to hedge all its exposure for 2026 and 75% for 2027. This extends the Goldilocks scenario of lower costs and higher revenues from 2026 into 2027 and supports approximately half of the company's guided adj. EBITDA ma...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch